Launch — Access limited to 250 Members to ensure personalized follow-up quality.

Biological Age: Five Approaches to Measuring How You Really Age

Two hourglasses side by side on a dark surface, one nearly empty and the other barely started

Biological age estimates the actual functional state of the body based on molecular, metabolic, and physiological markers. Unlike chronological age, which merely counts years, it quantifies the speed and extent of decline across biological systems. Two individuals aged 55 can diverge by more than 15 years in biological age depending on their inflammatory, metabolic, and epigenetic profile (PubMed ).

This divergence is not anecdotal. The Dunedin cohort study, following a thousand individuals since their birth in 1972-73, demonstrated that biological aging differences are already measurable at age 38. Some participants aged at a rate of 0.4 biological years per calendar year. Others at 2.4 biological years per calendar year. Six times faster. And this acceleration predicted cognitive decline, physical frailty, and older perceived appearance as rated by independent assessors (PubMed ).

The question is no longer whether biological aging differs from calendar aging. It is how to measure it. Five approaches exist today, each with its strengths and limitations.

Epigenetic clocks: the academic gold standard

DNA methylation (the addition of small chemical groups to specific letters of the genetic code) changes predictably over a lifetime. In 2013, Steve Horvath showed that 353 of these sites are sufficient to estimate chronological age with a median error of 3.6 years (PubMed ).

Since then, clocks have evolved. GrimAge, published in 2019, no longer measures age but mortality risk, by integrating epigenetic surrogates of plasma proteins associated with aging (PubMed ). DunedinPACE, developed by Belsky's team in 2022, measures the pace of aging rather than a static age: a score of 1.2 means the individual is aging 20% faster than average (PubMed ).

Epigenetic clocks remain the most validated method in research. Their limitation for the general public is threefold: high cost (€200 to €500 per test), need for a specialized laboratory, and variable reproducibility across commercial providers. For a deeper exploration of DNA methylation and clock mechanisms, we have devoted a dedicated article to this topic.

Blood biomarkers: the most accessible proxy

A standard blood draw contains a considerable amount of information about the aging trajectory. Several biomarkers, available in any clinical laboratory, are individually correlated with all-cause mortality and accelerated aging.

hs-CRP (high-sensitivity C-reactive protein) measures low-grade systemic inflammation, the process most consistently associated with aging across all organ systems. A chronically elevated hs-CRP (above 3 mg/L) is associated with increased cardiovascular risk, faster cognitive decline, and higher mortality (PubMed ).

HbA1c (glycated hemoglobin) reflects glycemic control over the past 2 to 3 months. Glucose dysregulation is one of the central mechanisms of accelerated aging. Each 1% increase in HbA1c above the normal threshold is associated with a significant increase in cardiovascular risk, even in non-diabetics (PubMed ).

Homocysteine is the byproduct of the one-carbon cycle that supplies the methyl groups required for DNA methylation (PubMed ). Its elevation signals a cycle under strain. A cross-sectional NHANES analysis of 2,346 adults aged 50 and over associates a doubling of plasma homocysteine with a 1.93-year acceleration on GrimAge2 (PubMed ).

HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) evaluates insulin resistance from fasting glucose and insulin levels. Insulin resistance is a metabolic crossroads of aging, linked to inflammation, ectopic lipid storage, and mitochondrial dysfunction (PubMed ).

Ferritin reflects the body's iron stores. Iron is a potent pro-oxidant: in excess, it catalyzes free radical formation through the Fenton reaction. A Mendelian randomization study links higher iron status to a shorter life expectancy (PubMed ). The method relies on iron-related genetic variants, allotted at random from conception, which limits the biases of mere observation.

None of these markers alone constitutes a "biological age." It is their combined reading, tracked over time, that reveals a trajectory. Several composite algorithms attempt to integrate these data into a single score. One of the most widely used is phenotypic age (PhenoAge), built by Morgan Levine. It combines chronological age with nine routine blood biomarkers: albumin, creatinine, glucose, CRP, lymphocyte percentage, mean cell volume, red cell distribution width, alkaline phosphatase and white blood cell count. From these it derives a biological age correlated with mortality (PubMed ).

9
PhenoAge biomarkers

Morgan Levine's phenotypic age combines nine routine blood biomarkers with chronological age. Built on the US NHANES health survey, it predicts all-cause mortality.

Plasma proteomics: aging in waves

Proteomics (the large-scale analysis of proteins circulating in the blood) opens an unprecedented window into systemic aging. Instead of measuring a few biomarkers, it measures thousands simultaneously.

The Lehallier et al. study (2019), covering 2,925 individuals aged 18 to 95, revealed an unexpected finding: proteomic aging does not progress linearly. It advances in waves, with major inflections around ages 34, 60, and 78 (PubMed ).

At 34, the first wave marks the transition between the end of biological maturation and the onset of decline. At 60, a massive shift in the plasma proteome suggests a profound reorganization of biological systems. At 78, the third wave coincides with entry into a zone of increased frailty.

These findings have two implications. The first is practical: aging is not a gradual process. There are windows of biological vulnerability. The second is methodological: a panel of a few blood proteins can predict chronological age with accuracy comparable to epigenetic clocks. The Ioannidis team showed that 373 proteins are sufficient to predict age within ±3 years (PubMed ).

Proteomics is currently a research tool, not a routine test. But high-throughput platforms (SomaScan, Olink) make measuring hundreds of proteins technically feasible at decreasing cost. This is probably the method that will evolve the most in the next five years.

Functional measurements: the body as an instrument

Molecular approaches are not the only ones. Simple physiological measurements are associated with biological aging with robustness sometimes comparable to that of blood biomarkers.

Walking speed is the most studied predictor. A meta-analysis of 34,485 individuals over 65 showed that each 0.1 m/s increase in walking speed is associated with a 12% reduction in mortality risk (PubMed ).

Grip strength (measured with a dynamometer) reflects functional muscle mass and neuromuscular function. Its decline is an early marker of sarcopenia and an independent predictor of all-cause mortality (PubMed ).

VO2max (maximal oxygen consumption) measures the capacity of the cardiovascular system and mitochondria to use oxygen. It declines with age, by approximately 10% per decade after age 30. A cohort of 122,007 adults referred for treadmill exercise testing estimated it, then ranked it by age and sex. The fittest 2.3% had a risk of death about five times lower than the least fit quarter (PubMed ).

These measurements are free, reproducible, and accessible. They do not provide a biological age number, but they capture the functional dimension that molecular biomarkers, by definition, do not measure.

Limitations: why biological age is not yet a standardized clinical tool

The diversity of methods is also a weakness. There is no consensus on the definition of a single "biological age." Each clock, each algorithm, each biomarker panel measures a different facet of aging. Two tests performed on the same day on the same individual can yield divergent results.

Test-retest reproducibility is a documented problem. In 2022, two analyses of the same DNA sample differed by up to 9 years for six widely used epigenetic clocks (PubMed ). Recalculated versions of these clocks, built to resist this measurement noise, brought most gaps below 1.5 years.

Cost remains a barrier. Epigenetic clocks cost €200 to €500 per test. Proteomic panels, €500 to €2,000. Only standard blood biomarkers are covered by healthcare systems.

Finally, the absence of prospective clinical validation limits the use of these tools in medical practice. Epigenetic clocks predict mortality in cohort studies, but no randomized trial has yet demonstrated that intervening based on biological age improves health outcomes compared to standard care.

Biological age as a longitudinal tracking metric

The value of biological age does not lie in a point-in-time number. It lies in its ability to trace a trajectory.

Comparable panels may show lower hs-CRP, stable HbA1c, and lower homocysteine. Read together, they outline a trajectory compatible with a favorable change in the biological profile. This trajectory does not establish that nutrition, physical activity, or sleep caused that change.

The purpose of longitudinal monitoring is to measure a slope rather than obtain a verdict. Its timing depends on the kinetics and uncertainty of the selected measures. Among Danish twins, genes explain only 20 to 25% of the differences in lifespan; the rest combines chance, environment and habits (PubMed ). The share that depends on habits supports monitoring; it does not turn an observed trajectory into causal evidence for any one factor.

Frequently asked questions


References

  1. Belsky DW, Caspi A, Houts R, et al. Quantification of biological aging in young adults. Proc Natl Acad Sci USA. 2015;112(30):E4104-E4110 (PubMed ).
  2. Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14(10):R115 (PubMed ).
  3. Lu AT, Quach A, Wilson JG, et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging (Albany NY). 2019;11(2):303-327 (PubMed ).
  4. Belsky DW, Caspi A, Corcoran DL, et al. DunedinPACE, a DNA methylation biomarker of the pace of aging. eLife. 2022;11:e73420 (PubMed ).
  5. Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347(20):1557-1565 (PubMed ).
  6. Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362(9):800-811 (PubMed ).
  7. Choi SW, Friso S. Modulation of DNA methylation by one-carbon metabolism: a milestone for healthy aging. Nutr Res Pract. 2023;17(4):597-615 (PubMed ).
  8. Bozack AK, Khodasevich D, Nwanaji-Enwerem JC, et al. One-carbon metabolism-related compounds are associated with epigenetic aging biomarkers: results from the cross-sectional National Health and Nutrition Examination Survey 1999-2002. Am J Clin Nutr. 2025;122(2):413-423 (PubMed ).
  9. López-Otín C, Blasco MA, Partridge L, et al. Hallmarks of aging: An expanding universe. Cell. 2023;186(2):243-278 (PubMed ).
  10. Daghlas I, Gill D. Genetically predicted iron status and life expectancy. Clin Nutr. 2021;40(4):2456-2459 (PubMed ).
  11. Levine ME, Lu AT, Quach A, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany NY). 2018;10(4):573-591 (PubMed ).
  12. Lehallier B, Gate D, Schaum N, et al. Undulating changes in human plasma proteome profiles across the lifespan. Nat Med. 2019;25(12):1843-1850 (PubMed ).
  13. Studenski S, Perera S, Patel K, et al. Gait speed and survival in older adults. JAMA. 2011;305(1):50-58 (PubMed ).
  14. Leong DP, Teo KK, Rangarajan S, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet. 2015;386(9990):266-273 (PubMed ).
  15. Mandsager K, Harb S, Cremer P, et al. Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing. JAMA Netw Open. 2018;1(6):e183605 (PubMed ).
  16. Higgins-Chen AT, Thrush KL, Wang Y, et al. A computational solution for bolstering reliability of epigenetic clocks: Implications for clinical trials and longitudinal tracking. Nat Aging. 2022;2(7):644-661 (PubMed ).
  17. Herskind AM, McGue M, Holm NV, et al. The heritability of human longevity: a population-based study of 2872 Danish twin pairs born 1870-1900. Hum Genet. 1996;97(3):319-323 (PubMed ).